Reggio PH |
Endocannabinoid binding to the cannabinoid receptors: what is known and what remains unknown. |
2010 |
Curr. Med. Chem. |
pmid:20166921
|
Maccarrone M |
Endocannabinoid-binding receptors: old friends and new comers. |
2010 |
Curr. Med. Chem. |
pmid:20441559
|
Kreitzer AC and Regehr WG |
Retrograde signaling by endocannabinoids. |
2002 |
Curr. Opin. Neurobiol. |
pmid:12049940
|
Ohno-Shosaku T and Kano M |
Endocannabinoid-mediated retrograde modulation of synaptic transmission. |
2014 |
Curr. Opin. Neurobiol. |
pmid:24747340
|
Bisogno T et al. |
Fatty acid amide hydrolase, an enzyme with many bioactive substrates. Possible therapeutic implications. |
2002 |
Curr. Pharm. Des. |
pmid:11945157
|
Fowler CJ |
"The tools of the trade"--an overview of the pharmacology of the endocannabinoid system. |
2008 |
Curr. Pharm. Des. |
pmid:18781976
|
Llorente R et al. |
Gender-dependent cellular and biochemical effects of maternal deprivation on the hippocampus of neonatal rats: a possible role for the endocannabinoid system. |
2008 |
Dev Neurobiol |
pmid:18666205
|
Engeli S et al. |
Activation of the peripheral endocannabinoid system in human obesity. |
2005 |
Diabetes |
pmid:16186383
|
Blüher M et al. |
Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity. |
2006 |
Diabetes |
pmid:17065342
|
Poursharifi P et al. |
Monoacylglycerol signalling and ABHD6 in health and disease. |
2017 |
Diabetes Obes Metab |
pmid:28880480
|
Di Marzo V et al. |
Changes in plasma endocannabinoid levels in viscerally obese men following a 1 year lifestyle modification programme and waist circumference reduction: associations with changes in metabolic risk factors. |
2009 |
Diabetologia |
pmid:18972095
|
González S et al. |
Behavioral and molecular changes elicited by acute administration of SR141716 to Delta9-tetrahydrocannabinol-tolerant rats: an experimental model of cannabinoid abstinence. |
2004 |
Drug Alcohol Depend |
pmid:15099659
|
Alhouayek M et al. |
Controlling 2-arachidonoylglycerol metabolism as an anti-inflammatory strategy. |
2014 |
Drug Discov. Today |
pmid:23891880
|
Muccioli GG |
Endocannabinoid biosynthesis and inactivation, from simple to complex. |
2010 |
Drug Discov. Today |
pmid:20304091
|
Thieme U et al. |
Quantification of anandamide and 2-arachidonoylglycerol plasma levels to examine potential influences of tetrahydrocannabinol application on the endocannabinoid system in humans. |
2014 Jan-Feb |
Drug Test Anal |
pmid:24424856
|
Jyotaki M et al. |
Modulation of sweet taste sensitivity by orexigenic and anorexigenic factors. |
2010 |
Endocr. J. |
pmid:20431269
|
Raff H et al. |
Increase in the circulating endocannabinoid 2-arachidonoylglycerol is associated with gabapentin use in septic ICU patients. |
2017 |
Endocrine |
pmid:28875451
|
Forner-Piquer I et al. |
Dose-Specific Effects of Di-Isononyl Phthalate on the Endocannabinoid System and on Liver of Female Zebrafish. |
2017 |
Endocrinology |
pmid:28938452
|
Melck D et al. |
Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation. |
2000 |
Endocrinology |
pmid:10614630
|
Farkas I et al. |
Retrograde endocannabinoid signaling reduces GABAergic synaptic transmission to gonadotropin-releasing hormone neurons. |
2010 |
Endocrinology |
pmid:20926585
|